Astellas Pharma Inc. (4503)

2,128.0 -0.5 (-0.02%)
Close JPY Disclaimer

4503 Income Statement

Total Revenue
Total Operating Expenses
Operating Income
Name
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
380,394 340,627 325,523 - -
Revenue 380,394 340,627 325,523 - -
Other Revenue, Total 0 - - - -
62,781 69,359 62,504 - -
317,613 271,268 263,019 - -
295,083 261,425 271,445 - -
Selling/General/Admin. Expenses, Total 154,560 135,914 133,397 - -
Research & Development 65,170 58,588 60,747 - -
Depreciation / Amortization 22,852 8,036 7,868 6,416 -
Interest Expense (Income) - Net Operating -1,508 -1,724 -16 - -
Unusual Expense (Income) -104 -5,508 2 - -
Other Operating Expenses, Total -8,772 -3,072 8,395 - -
85,311 79,202 54,078 - -
3,168 -885 -823 - -
2 - - - -
-3,493 -1 - - -
88,802 78,317 53,255 - -
17,179 17,431 12,333 - -
71,623 60,886 40,922 - -
- - - - -
- - - - -
- - - - -
71,623 60,886 40,922 - -
0 0 - - -
71,623 24,812 60,886 40,922 -
0 0 -1 -1 -
71,623 60,885 40,922 - -
0.56 -1.08 - - -
71,622.44 24,813.08 60,885 40,922 -
1,823.38 1,825.83 1,852.91 1,853.78 -
39.28 32.86 22.07 - -
30 0 25 - -
30.44 10.79 30.55 22.08 -

* In Millions of JPY (except for per share items)

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles